Navigation Links
Roche and Catalyst Resources Team to Explore RIA Healthcare Collaboration Solutions for Enhanced Clinical Diagnosis and Education
Date:1/20/2010

The rapid design project by Catalyst Resources enabled Roche executives and healthcare professionals to visualize how a sophisticated RIA could leverage Roche technologies and enable real-time collaboration and analysis by clinical staff of advanced diagnostic activities, all within a secure and scalable environment.

(PRWEB) January 20, 2010 -- Catalyst Resources, the global leader in Rich Internet Application (RIA) design for mission critical applications, today announced their work with Roche, the world's leading research-focused healthcare diagnostics group, to rapidly define product concepts for online diagnostic collaboration solutions using the latest RIA technologies.

The rapid design project enabled executives and healthcare professionals to visualize how a sophisticated RIA could leverage Roche technologies and enable real-time collaboration and analysis by clinical staff of advanced diagnostic activities, all within a secure and scalable environment.

Catalyst developed the prototype using a user interface/RIA swat team consisting of an on-site designer working with a distributed team of off-site developers and application architects.

By bridging Roche on-line and off-line medical services together in one place for medical information sharing, the Catalyst prototypes helped Roche identify service scenarios and visualize products that would cost-effectively improve the effectiveness of diagnosis, medical consultations and even patient education.


-- About Catalyst --
Catalyst specializes in the unique demands of scalable, modular and reusable UI for Software as a Service (SaaS), Healthcare, financial services and Rich Internet Application design. Since 1994, Catalyst Resources has successfully delivered user interface design for more than 300 mission critical software applications to leading global firms including ADP, Applied Biosystems, Cisco, HP, InterCall, Leukemia Society, SAP, and Ventana Medical. Headquartered in the Silicon Valley, Catalyst Resources employs accomplished UI designers, information architects, developers and business professionals. More information about Catalyst Resources can be found at www.catalystresources.com.

-- About Roche --
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world’s biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. Worldwide, the Group employs about 80,000 people. Additional information is available on the Internet at roche.com.

###

Read the full story at http://www.prweb.com/releases/healthcare/ria/prweb3473304.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. FDA Approves New Roche West Nile Virus Blood Screening Test
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. U.S. Reps. Oberstar and Walz Discuss DM&E Railroad Expansion With Rochester, Minn. Leaders
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
6. MacroChem Announces Preferred Stock Conversions and $3.5 Million Private Placement
7. Nations Largest Healthcare Alliance Adds Roche HIV-1 Test to Existing Contract
8. Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments
9. Roche Extends Tender Offer for Ventana
10. Roche Offers Innovative Website Designed to Empower Cancer Patients
11. Neurochem reports results for third quarter of fiscal 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality ... problems, I focus on preventative care with all my patients to alleviate possible future issues. ... feel free to contact my office and my trained staff will assist you in any ...
(Date:4/25/2017)... ... ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will be featured ... publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is an Emergency ... He also serves as Medical Director for the Bureau of Emergency Medical Services and ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and ... This is in conjunction with this morning,s announcement of ... Thrombosis and Nutritional Insufficiency businesses. Cardinal Health ... operations will be at the bottom of its previous ...
Breaking Medicine Technology: